I-FDA inikeze imvume esheshayo ye-mobocertinib yomdlavuza wamaphaphu weseli ongeyona omncane nge-EGFR exon 20

Septhemba 2021: I-FDA yanikeza imvume esheshayo ku-mobocertinib (i-Exkivity, Takeda Pharmaceuticals, Inc.) yeziguli ezindala ezinomdlavuza wamaphaphu wesifo samangqamuzana (i-NSCLC) esithuthukile endaweni noma esine-metastatic non-small.

IKRAS G12C, Ikhithi ye-KRAS RGQ PCR, I-RAS GTPase, sotorasib

USotorasib uthola imvume esheshayo evela kwi-FDA ye-KRAS G12C mutant NSCLC

Agasti 2021: I-FDA inikeze imvume esheshayo ku-sotorasib (Lumakras TM, Amgen, Inc.), i-RAS GTPase yomndeni inhibitor, yeziguli ezindala ezine-KRAS G12C ezishintshe umdlavuza wamaphaphu wesisu ongaphakeme noma we-metastatic (NSCLC) w ..

ALK, B7461006, i-crizotinib, I-Lorbrena, iloratinib, I-NCT03052608, Pfizer, IVentana ALK, Izinhlelo zeVentana Medical

ILorlatinib ivunyelwe yi-FDA ekwelashweni kwe-NSCLC ye-ALK-positive metastatic.

Agasti 2021: I-Lorlatinib (i-Lorbrena, i-Pfizer Inc.) ithole ukuvunyelwa okujwayelekile kwe-FDA kweziguli ezinomdlavuza we-metastatic non-small cell lung cancer (NSCLC) ezinamathumba azo yi-anaplastic lymphoma kinase (ALK) -positive, njengoba kunqunywe uhlelo lokusebenza lwe-FDA ..

i-anaplastic lymphoma kinase, B7461006, I-CDx Assay, Ukuphathwa Kwezokudla Nezidakamizwa, I-Lorbrena, iloratinib, I-NCT03052608, I-NSCLC, Pfizer, IVentana ALK, Izinhlelo zeVentana Medical

ILorlatinib ivunyelwe yi-FDA ekwelashweni kwe-NSCLC ye-ALAS-positive metastatic

Agasti 2021: I-Lorlatinib (i-Lorbrena, i-Pfizer Inc.) ithole ukuvunyelwa okujwayelekile kwe-FDA kweziguli ezinomdlavuza we-metastatic non-small cell lung cancer (NSCLC) ezinamathumba azo yi-anaplastic lymphoma kinase (ALK) -positive, njengoba kunqunywe uhlelo lokusebenza lwe-FDA ..

cemiplimab-rwlc, I-Egfr, FDA, Ukuphathwa Kwezokudla Nezidakamizwa, I-NCT03088540, I-NSCLC, Isisho se-PD-L1

I-Cemiplimab-rwlc ivunyelwe yi-FDA yomdlavuza wamangqamuzana ongewona omncane onenkulumo ephezulu ye-PD-L1

Agasti 2021: I-FDA ivume i-cemiplimab-rwlc (iLibtayo, iRegeneron Pharmaceuticals, Inc.) ekwelashweni komugqa wokuqala kweziguli ezinomdlavuza wamaphaphu wesifo samangqamuzana (non-small advanced advanced (NSCLC)).

FDA, IKRAS G12C, I-Lumakras, I-NSCLC, sotorasib

I-FDA igunyaze ukwelashwa okuhlosiwe kokuqala kokuguqulwa komdlavuza wamaphaphu okwakucatshangwa ukuthi awuzweli emishanguzweni.

Agasti 20, 2021: Muva nje ngoMeyi, i-2021 Lumakras (sotorasib) yamukelwa yi-US Food and Drug Administration njengokwelashwa kokuqala kweziguli ezindala ezinomdlavuza ongewona omncane wamangqamuzana wamaphaphu asebenze okungenani uhlelo olulodwa lwangaphambilini ..

Cigarettes

Iziguli ezingaphezu kuka-12% ezisanda kutholakala zomdlavuza wamaphaphu zisabhema osikilidi - ucwaningo lukhombisa

NgoJulayi 7th 2021: Ukubhema ugwayi kuyimbangela ehamba phambili yomdlavuza wamaphaphu, okubalwa ngaphezu kwama-80% abo bonke abantu ababulawa yilesi sifo. Abantu abangabhemi, nokho, banomdlavuza wamaphaphu. Ngokwesifundo esisha, arou ..

Ukumelana nezidakamizwa emdlavuzeni wesifo samaphaphu ongeyona omncane

Okufanele ukwenze ngokumelana nemithi yezidakamizwa ezibhekiswe kumdlavuza wamangqamuzana ongewona omncane, ufuna ukwazi lapha Umdlavuza wamaphaphu ngumdlavuza onesifo esiphakeme kakhulu nokufa kwabantu eChina. Cishe abantu abayizigidi eziyi-1.6 babulawa yilesi sifo yebo yebo ..

Ukwelashwa kwe-PD-1 ne-PD-l1 yomdlavuza wamaphaphu

Lung cancer immunotherapy, lung cancer immunotherapy, lung cancer PD-1 treatment, and lung cancer PD-L1 treatment are all you want to know. In the past two years, immune checkpoint inhibitors have undoubtedly been one of the most..

I-Brigatinib yomdlavuza we-ALK-positive crizotinib non-small cell lung cancer

Izazi zikaDong-Wan Kim ezivela eSeoul National University Hospital eSouth Korea zizonikeza umbiko ngomlomo ngomhlangano okhethekile womdlavuza wamaphaphu weseli ongasona omncane eMhlanganweni Wonyaka wama-52 we-American Society of Oncolo ..